��ɫ��

��ɫ��

Donate To Research Join The AAN

Events

Resources For

Abstract Details

Title Psychological Impact of the Neurofibromatosis Tumor Suppressor Syndrome in Adults

Topic Neuro-oncology

Presentation(s) (-)

Poster/Presentation
Number 253

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Daphne Wang	No disclosure on file
	No disclosure on file
Atchayaram Nalini, MBBS (National Inst of Mental Health & Neurosciences)	No disclosure on file
	No disclosure on file
Fawn Leigh, MD	No disclosure on file
Alona Muzikansky	No disclosure on file
	No disclosure on file
Scott R. Plotkin, MD, PhD, FAAN (Mass General Cancer Center)	Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.